LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release second quarter 2016 financial results after the market close on Monday, August 1, 2016. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PDT (4:30 p.m. EDT) on August
FORT WORTH, Texas & SAN FRANCISCO–(BUSINESS WIRE)–TPG Capital today announced it has entered into a definitive agreement to purchase Beaver-Visitec International.
By combining data on optometry patients’ eyes with advanced computational methods, Indiana University researchers have created a virtual tissue model of diabetes in the eye.
Allergan has filed a de novo application to the FDA for the Oculeve intranasal tear neurostimulator, according to a company press release. The hand-held stimulator can temporarily increase tear production in patients with dry eye disease due to decreas…
HARTFORD, Conn.–(BUSINESS WIRE)–The Hartford integrated dental and vision coverage with its group disability and life insurance enabling brokers to create full benefits packages for small businesses with fewer than 50 employees.
The most trending articles on Healio.com/OSN from the European Glaucoma Society Congress were video perspectives from key opinion leaders who shared their perspectives on trending topics related to glaucoma treatment.